Enliven Therapeutics

ELVN NASDAQ
Overview Stats Financials News

Quarterly Financials

Values in thousands 2024-03-31 2023-12-31 2023-09-30 2023-06-30
Revenue $0 $440 $0 $0
Gross Profit -79 363 -79 -74
EBITDA -25,908 -22,652 -24,170 -20,060
EBIT -25,987 -22,729 -24,248 -20,134
Net Income -22,738 -19,370 -20,769 -16,721
Net Change In Cash 0 440 0 0
Free Cash Flow -23,381 -12,496 -15,910 -12,137
Cash 149,219 100,195 73,847 125,715
Basic Shares 42,045 41,128 41,030 40,961

Annual Financials

Values in thousands 2023-12-31 2022-12-31 2021-12-31 2020-12-31
Revenue $0 $0 $0 $0
Gross Profit -297 -622 -99 -97
EBITDA -83,232 -38,576 -24,647 -9,273
EBIT -83,529 -38,791 -24,762 -9,318
Net Income -71,584 -37,750 -24,718 -18,935
Net Change In Cash 0 0 0 0
Free Cash Flow -61,418 -32,689 -19,325 -8,990
Cash 100,195 75,536 110,024 130,365
Basic Shares 35,546 3,124 2,306 3,481

Earnings Calls

Quarter EPS
2024-03-31 -$0.54
2023-12-31 -$0.47
2023-09-30 -$0.51
2023-06-30 -$0.41